Baker Bros. Advisors LP Heron Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $28.4 Million - $39.5 Million	2,136,974 Added 35.65%	8,131,678 $126 Million
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $319,878 - $415,818	-23,400 Reduced 0.39%	5,994,704 $88.8 Million
Q2 2019 Aug 14, 2019	BUY	$16.93 - $26.22 $16.9 Million - $26.2 Million	1,000,000 Added 19.93%	6,018,104 $112 Million
Q4 2018 Feb 13, 2019	SELL	$22.03 - $32.01 $158,483 - $230,279	-7,194 Reduced 0.14%	5,018,104 $130 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $36.2 Million - $56.6 Million	1,964,657 Added 64.19%	5,025,298 $139 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $4.04 Million - $5.14 Million	272,649 Added 9.78%	3,060,641 $55.4 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $40.8 Million - $47 Million	2,787,992	2,787,992 $45 Million

173

114M

32.4K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $204M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.